Last reviewed · How we verify
Lidocaine 4%
Lidocaine 4% is a Amide Local Anesthetic [EPC] Small molecule drug developed by Rigshospitalet, Denmark. It is currently FDA-approved. Also known as: Lidocaine Pain Relief Patch, Xylocaine, Liquid Lidocaine, LMX4.
At a glance
| Generic name | Lidocaine 4% |
|---|---|
| Also known as | Lidocaine Pain Relief Patch, Xylocaine, Liquid Lidocaine, LMX4 |
| Sponsor | Rigshospitalet, Denmark |
| Drug class | Amide Local Anesthetic [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- OMT for Adhesive Capsulitis (PHASE4)
- Sphenopalatine Ganglion Block for Post-Dural Puncture Headache: A Pilot Randomised Controlled Trial (NA)
- Effects of Different Drugs for Glottic Atomization on Postoperative Sore Throat After Thyroid Surgery (PHASE4)
- USG-Guided Shoulder Injections in Frozen Shoulder (NA)
- Comparison of the Effectiveness of Exercise, Dry Needling and Interfascial Block Treatments in the Treatment of Myofascial Pain Syndrome (NA)
- Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (PHASE4)
- Bladder Directed vs. Pelvic Floor Therapy in IC/BPS (PHASE2)
- Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lidocaine 4% CI brief — competitive landscape report
- Lidocaine 4% updates RSS · CI watch RSS
- Rigshospitalet, Denmark portfolio CI
Frequently asked questions about Lidocaine 4%
What is Lidocaine 4%?
Lidocaine 4% is a Amide Local Anesthetic [EPC] drug developed by Rigshospitalet, Denmark.
Who makes Lidocaine 4%?
Lidocaine 4% is developed and marketed by Rigshospitalet, Denmark (see full Rigshospitalet, Denmark pipeline at /company/rigshospitalet-denmark).
Is Lidocaine 4% also known as anything else?
Lidocaine 4% is also known as Lidocaine Pain Relief Patch, Xylocaine, Liquid Lidocaine, LMX4.
What drug class is Lidocaine 4% in?
Lidocaine 4% belongs to the Amide Local Anesthetic [EPC] class. See all Amide Local Anesthetic [EPC] drugs at /class/amide-local-anesthetic-epc.
What development phase is Lidocaine 4% in?
Lidocaine 4% is FDA-approved (marketed).
Related
- Drug class: All Amide Local Anesthetic [EPC] drugs
- Manufacturer: Rigshospitalet, Denmark — full pipeline
- Also known as: Lidocaine Pain Relief Patch, Xylocaine, Liquid Lidocaine, LMX4
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing